CDT Equity Inc. is projected to decline to $0.369 by 2027, a -3% move from its current price of $0.3812. CDT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3443 | $0.3809 | $0.4213 | -0.09% |
| Jul 14 | $0.3299 | $0.3805 | $0.4389 | -0.17% |
| Jul 15 | $0.3193 | $0.3802 | $0.4528 | -0.26% |
| Jul 16 | $0.3105 | $0.3799 | $0.4648 | -0.34% |
| Jul 17 | $0.3029 | $0.3796 | $0.4756 | -0.43% |
| Jul 18 | $0.2962 | $0.3792 | $0.4856 | -0.51% |
| Jul 19 | $0.2901 | $0.3789 | $0.4949 | -0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2901 | $0.3789 | $0.4949 | -0.60% |
| Week 2 | $0.2582 | $0.3767 | $0.5494 | -1.19% |
| Week 3 | $0.2358 | $0.3744 | $0.5945 | -1.78% |
| Week 4 | $0.2182 | $0.3722 | $0.6348 | -2.37% |
| Week 5 | $0.2036 | $0.3699 | $0.672 | -2.95% |
| Week 6 | $0.1912 | $0.3677 | $0.7072 | -3.53% |
| Week 7 | $0.1804 | $0.3655 | $0.7408 | -4.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CDT Equity Inc. is a data-driven biopharmaceutical company focused on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator in Phase II trials for autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, in Phase I for Type 2 Diabetes; and AZD5904, which has completed Phase I trials for idiopathic male infertility.
It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc.
in August 2025. CDT Equity was founded in 2019 and is based in Naples, Florida.
CDT Equity Inc. (CDT) is a healthcare company with a current price of $0.3812 and a market capitalization of $1.85M. It ranks 5424 by market cap. The stock trades near a defined support level of $0.381 and faces resistance around $1.50.
The 30-day technical picture is neutral, with RSI14 at 30, and moving averages showing a price well below shorter- and longer-term trends (SMA50 at $1.15 and SMA200 at $33.48). The 30-day range spans from $0.196 to $0.7414, and annualized volatility stands at 200%. Forecasts indicate a multi-year horizon with periods of upside, including bullish years in the latter 2020s and beyond, supported by a series of year-by-year projections.
A major floor 0.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 293.5% above — a clean break opens room to run.
A major ceiling 4543.2% above — clearing it would confirm fresh momentum.
Key CDT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4254 | Sell | $0.4346 | Sell |
| MA 10 | $0.4924 | Sell | $0.5186 | Sell |
| MA 20 | $0.6966 | Sell | $0.6816 | Sell |
| MA 50 | $1.15 | Sell | $2.42 | Sell |
| MA 100 | $5.98 | Sell | $73.17 | Sell |
| MA 200 | $33.48 | Sell | $8,470.97 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.39 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -102.82 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -66.87 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -3.27 | Sell |
| Awesome (5,34) | -0.36 | Sell |
| Ultimate (7,14,28) | 14.47 | Buy |
| Momentum (10) | -0.33 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.38 | Sell |
| ADX (14) | 35.27 | Sell |
| ATR (14) | 0.10 | Info |
The 30-day technical picture for CDT Equity Inc. is NEUTRAL, with RSI14 at 30. The price sits near support at $0.381 and remains well below the short-term and long-term moving averages (SMA50 at $1.15; SMA200 at $33.48).
The 30-day range runs from $0.196 to $0.7414, highlighting a wide swing while the asset remains near its current level and beneath key resistance at $1.50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.381 | $0.3812 | $0.4499 | 0% | Neutral | |
| $0.2677 | $0.369 | $0.5498 | -3% | Neutral | |
| $0.281 | $0.4116 | $0.6536 | +8% | Neutral | |
| $0.3296 | $0.5085 | $0.8478 | +33% | Bullish | |
| $0.3217 | $0.5204 | $0.9031 | +37% | Bullish | |
| $0.2523 | $0.4266 | $0.7663 | +12% | Neutral | |
| $0.2219 | $0.3913 | $0.7249 | +3% | Neutral | |
| $0.225 | $0.4132 | $0.7867 | +8% | Neutral | |
| $0.2998 | $0.5726 | $1.12 | +50% | Bullish | |
| $0.3225 | $0.6403 | $1.28 | +68% | Bullish | |
| $0.3369 | $0.7487 | $1.64 | +96% | Bullish | |
| $0.4327 | $0.9616 | $2.21 | +152% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.381 | $0.3812 | $0.455 | +0.00% |
| August 2026 | $0.2838 | $0.3437 | $0.4335 | -9.84% |
| September 2026 | $0.287 | $0.3526 | $0.4541 | +2.58% |
| October 2026 | $0.3019 | $0.3754 | $0.492 | +6.49% |
| November 2026 | $0.2843 | $0.3573 | $0.475 | -4.84% |
| December 2026 | $0.2632 | $0.334 | $0.4499 | -6.52% |
Click any year to see its month-by-month CDT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CDT could reach as high as $0.4499, with a base case around $0.3812 and support toward $0.381 — roughly 0% from $0.3812. Price action looks broadly range-bound.
Expect CDT to range from $0.2677 to $0.5498 through 2027. The $0.369 average target implies a -3% move from current prices. That is -3% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The CDT price prediction for 2028 points to an average of $0.4116 (low $0.281, high $0.6536) — a potential gain of +8% on today's $0.3812. Price action looks broadly range-bound.
In 2029, CDT is projected to trade between $0.3296 and $0.8478, averaging $0.5085 — a potential gain of +33% from today's $0.3812. That is up +24% on the projected 2028 average. Buyers look set to stay in control over this stretch.
CDT Equity Inc.'s 2030 outlook centres on $0.5204, within a $0.3217 to $0.9031 range. That is up +2% on the projected 2029 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2031, CDT could reach as high as $0.7663, with a base case around $0.4266 and support toward $0.2523 — roughly +12% from $0.3812. A consolidation phase looks the most probable path here.
Expect CDT to range from $0.2219 to $0.7249 through 2032. The $0.3913 average target implies a +3% move from current prices. That is -8% versus the projected 2031 average. Price action looks broadly range-bound.
The CDT price prediction for 2033 points to an average of $0.4132 (low $0.225, high $0.7867) — a potential gain of +8% on today's $0.3812. A consolidation phase looks the most probable path here.
In 2034, CDT is projected to trade between $0.2998 and $1.12, averaging $0.5726 — a potential gain of +50% from today's $0.3812. That is up +39% on the projected 2033 average. Momentum favours further upside here.
CDT Equity Inc.'s 2035 outlook centres on $0.6403, within a $0.3225 to $1.28 range. That is up +12% on the projected 2034 average. That marks a +68% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CDT could reach as high as $1.64, with a base case around $0.7487 and support toward $0.3369 — roughly +96% from $0.3812. Momentum favours further upside here.
Expect CDT to range from $0.4327 to $2.21 through 2050. The $0.9616 average target implies a +152% move from current prices. That is up +28% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CDT today (≈ 2,623.294858 CDT) could be worth
$2,522.69
+$1,522.69 (+152%) by 2050 · US Dollar
Based on the average projected CDT price of $0.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDTwould be worth at today's price.
$1,000 invested in CDT on Jul 10, 2025 (≈ 2.074689 CDT) would be worth
$0.79
-$999.21 (-99.9%) today · 0.00× · US Dollar
Based on a CDT entry price of $482 vs. today's $0.3812.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.494 | $771.66 | -22.8% |
| 1 month ago | $0.72 | $529.44 | -47.1% |
| 3 months ago | $4.08 | $93.43 | -90.7% |
| 6 months ago | $36.75 | $10.37 | -99.0% |
| 1 year ago | $482 | $0.79 | -99.9% |
| All time (4.3y) ago | $2,982,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDT forecast.
Our base-case forecast reaches $0.76 around 2050.
Implied market cap at $0.76: $3.69M
The forecast provides a multi-year outlook with selective bullish periods. For 2026, the min price is $0.381, the avg is $0.3812, the max is $0.4499, with ROI of 0 and a NEUTRAL sentiment. In 2029, the avg rises to $0.509 and the max to $0.8487, with a 33.5% ROI and a BULLISH sentiment.
The 2030 forecast shows an avg of $0.5212, a max of $0.9047, a 36.7% ROI, and a BULLISH sentiment. The path continues through 2034 with a min of $0.2992, an avg of $0.5715, a max of $1.12, 49.9% ROI, and a BULLISH sentiment, and 2035 with a min of $0.3226, an avg of $0.6406, a max of $1.28, 68% ROI, and a BULLISH sentiment. By 2040 the avg is $0.7477, the max $1.64, the ROI 96.1%, and sentiment remains BULLISH.
In 2050, the avg reaches $0.9622 with a max of $2.21, a 152.4% ROI, and a BULLISH sentiment. These figures suggest potential upside over the long term, though they are estimates and not guarantees. Drivers and risks are inherent in long-horizon projections and depend on factors not specified here.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.5212, with a minimum of $0.3222 and a maximum of $0.9047, and an estimated ROI of 36.7% with a BULLISH sentiment.
Forecasts show several bullish years (e.g., 2029, 2030, 2034–2035, 2040, 2050) with notable ROI figures (e.g., 33.5% in 2029, 36.7% in 2030, 96.1% in 2040, and 152.4% in 2050), though some years are Neutral or have negative ROI (e.g., 2027 at -3%). These are estimates and not guarantees.
Yes. The forecast maximums include $1.28 in 2035 and $1.64 in 2040, with a further max of $2.21 in 2050, indicating potential to surpass $1 in multiple future years.
Current price is $0.3812 and market cap is $1.85M.
The 30-day picture is NEUTRAL with RSI14 at 30. The price is near support at $0.381, with a 30-day range from $0.196 to $0.7414 and moving averages of SMA50 at $1.15 and SMA200 at $33.48, indicating the price is well below longer-term averages.
CDT Equity Inc. Community Discussion
0Share your CDT Equity Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.